309 related articles for article (PubMed ID: 36515514)
21. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
[TBL] [Abstract][Full Text] [Related]
23. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
24. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
26. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
Izquierdo KM; Humphries MD; Farkas LM
Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years.
Ghabra S; Desale S; Sugarbaker PH
Dis Colon Rectum; 2023 Oct; 66(10):1329-1338. PubMed ID: 36856661
[TBL] [Abstract][Full Text] [Related]
28. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
29. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
[TBL] [Abstract][Full Text] [Related]
30. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
[TBL] [Abstract][Full Text] [Related]
31. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
[TBL] [Abstract][Full Text] [Related]
32. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
[TBL] [Abstract][Full Text] [Related]
33. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
[TBL] [Abstract][Full Text] [Related]
34. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
[TBL] [Abstract][Full Text] [Related]
35. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
[TBL] [Abstract][Full Text] [Related]
36. Effect of Tumor Location on Outcome After Laparoscopic Low Rectal Cancer Surgery: A Propensity Score Matching Analysis.
Wu Q; Jin Z; Zhang X; Deng X; Peng Y; Wang Z
Dis Colon Rectum; 2022 May; 65(5):672-682. PubMed ID: 35394940
[TBL] [Abstract][Full Text] [Related]
37. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
39. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
[TBL] [Abstract][Full Text] [Related]
40. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]